Category Matches
- 5-HT1 Receptors - Analgesics
- 5-HT2 Receptors - Analgesics
- 5-HT3 Receptors - Analgesics
- 5-HT5 Receptors - Analgesics
- 5-HT6 Receptors - Analgesics
- 5-HT7 Receptors - Analgesics
- 5-Lipoxygenase Inhibitors
- Activin-like Kinase
- Adenosine Receptors - Analgesics
- Adrenal Hormones and Modulators
- Adrenergic Receptors - Analgesics
- Aldosterone and ENaC Antagonists (K+ Sparing diuretics)
- Alkyl Sulfonates
- AMPA - Analgesics
- anabasine
- Analgesics and Antinociceptives
- anastrozole
- anatabine
- Anti-anginal
- Antihistamines - Therapies for Respiratory Diseases and Allergy Management
- Antimicrobial Peptides - Natural Products
- artesunate
- Beta Blockers - Anti-anginal
- bifonazole
- Bisphosphonates
- Ca2+ Channel Blockers - Anti-anginal
- Ca2+ Channel Blockers - Antihypertensive
- Ca2+ Channel Blockers - Vasodilatory
- Ca2+ Channels - Analgesics
- Ca2+ Channels - Anesthetic
- Ca2+ Channels - Antidepressant
- Ca2+ Channels - Antiepileptics and Anticonvulsants
- Ca2+ Channels - Antipsychotic
- Ca2+ Channels - Anxiolytic
- Ca2+ Channels - Cognition Enhancing
- Ca2+ Channels - Sedatives
- Ca2+ Ion Channels - Neurodegenerative Diseases
- Cannabinoid Receptors - Analgesics
- Cannabinoid Receptors - Antidepressant
- Cannabinoid Receptors - Anxiolytic
- Cannabinoid Receptors - Sedatives
- Cell Membrane Modifiers
- Class I (Na+ Channel Blocker)
- Class III (K+ Channel Blocker)
- Class IV (Ca2+ Channel Blocker)
- Compounds targeting DNA synthesis and repair
- coronavirus
- Cough Management
- COX - Analgesics
- COX-1 - Analgesics
- COX-2 - Analgesics
- cyproconazole
- D-amino Acid Oxidase - Analgesics
- D1 Receptors - Analgesics
- D2 Receptors - Analgesics
- D3 Receptors - Analgesics
- D4 Receptors - Analgesics
- DA Receptor Signaling - Analgesics
- DA Receptor Signaling - Anesthetic
- DA Receptor Signaling - Antidepressant
- DA Receptor Signaling - Antipsychotic
- DA Receptor Signaling - Anxiolytic
- DA Receptor Signaling - Cognition Enhancing
- DA Receptor Signaling - Neurodegenerative Diseases
- DA Receptor Signaling - Sedatives
- darunavir
- diclofenac
- difenoconazole
- dinaciclib
- DNA and RNA Synthesis Inhibitors
- DNA Crosslinking and Alkylating Agents
- DNA Methyltransferase
- DNA Polymerase
- DNA Strand Break-Inducing Agents
- DNA-PK
- Endocrine Signaling and Immunology
- Epigenetic Modifiers
- epoxiconazole
- external
- fexofenadine
- GABA - Analgesics
- Gastrointestinal Motility Modulators
- GDC-0941
- GDC-0973
- GDC-0980
- GSK-3 - Analgesics
- Gut/Gastrointestinal Hormones
- Histamine Receptors - Analgesics
- Imidazoline Receptors - Analgesics
- indinavir
- Indoleamine 2,3-dioxygenase
- Ion Channels - Analgesics
- Ion Channels - Anesthetic
- Ion channels - Antidepressant
- Ion Channels - Antiepileptics and Anticonvulsants
- Ion Channels - Antipsychotic
- Ion Channels - Anxiolytic
- Ion Channels - Cognition Enhancing
- Ion Channels - Hypnotics
- Ion Channels - Neurodegenerative Diseases
- Ion Channels - Sedatives
- Isothiocyanate
- K+ ATP Channel Blockers
- K+ Channels - Analgesics
- K+ Channels - Anesthetic
- K+ Channels - Antidepressant
- K+ Channels - Antiepileptics and Anticonvulsants
- K+ Channels - Antipsychotic
- K+ Channels - Anxiolytic
- K+ Channels - Cognition Enhancing
- K+ Channels - Hypnotics
- K+ Channels - Sedatives
- K+ Ion Channels - Neurodegenerative Diseases
- Lipoxygenase - Analgesics
- Lopinavir
- mAChR - Analgesics
- MAO - Analgesics
- Melatonin Receptors - Analgesics
- N-Arylanthranilic acid Derivatives (Fenamates)
- Na+ Channels - Analgesics
- Na+ Channels - Anesthetic
- Na+ Channels - Antidepressant
- Na+ Channels - Antiepileptics and Anticonvulsants
- Na+ Channels - Antipsychotic
- Na+ Channels - Anxiolytic
- Na+ Channels - Cognition Enhancing
- Na+ Channels - Sedatives
- Na+ Ion Channels - Neurodegenerative Diseases
- nAChR
- nAChR - Analgesics
- nAChR - Anesthetic
- nAChR - Antidepressant
- nAChR - Antiepileptics and Anticonvulsants
- nAChR - Anxiolytic
- nAChR - Cognition Enhancing
- nAChR - Neurodegenerative Diseases
- nAChR - Sedatives
- nanoparticle
- nanostructure lipid carrier
- Naphthoquinone
- Natural Products
- NET - Analgesics
- NK - Analgesics
- NMDA - Analgesics
- Nucleoside and Nucleotide Analogs
- Nucleoside/Nucleotide analogs
- Opioid Receptors - Analgesics
- Other Analogs
- Other DA Signaling - Analgesics
- Other DA Signaling - Anesthetic
- Other DA Signaling - Antidepressant
- Other DA Signaling - Antipsychotic
- Other DA Signaling - Anxiolytic
- Other DA Signaling - Cognition Enhancing
- Other DA Signaling - Neurodegenerative Diseases
- Other DA Signaling - Sedatives
- Other Ion Channels - Analgesics
- Other Ion Channels - Anesthetic
- Other Ion Channels - Antidepressant
- Other Ion Channels - Antiepileptics and Anticonvulsants
- Other Ion Channels - Antipsychotic
- Other Ion Channels - Anxiolytic
- Other Ion Channels - Cognition Enhancing
- Other Ion Channels - Sedatives
- Others - Cell Membrane Modifiers
- Ponatinib
- ponatinib
- Prostaglandin Synthetase - Analgesics
- Quinazoline
- ritonavir
- RNA
- RNA Polymerase
- saquinavir
- Serine/Threonine Kinase Inhibitors
- Serotonin Receptors - Analgesics
- SERT - Analgesics
- Snake Venoms
- Sulfonamides
- tebuconazole
- Therapies for Respiratory Diseases and Allergy Management
- thiocyanate
- tipranavir
- Transcription Factor Modifiers
- TRP Channels - Analgesics
- TRP Channels - Anesthetic
- TRP Channels - Antidepressant
- TRP Channels - Antiepileptics and Anticonvulsants
- TRP Channels - Antipsychotic
- TRP Channels - Anxiolytic
- TRP Channels - Cognition Enhancing
- TRP Channels - Neurodegenerative Diseases
- TRP Channels - Sedatives
- TRPV4
- Tyrosine Kinase Inhibitors
- Website Updates
Product Matches
- I524086Incensol
Component of Frankincense resin.
≥98% - I524088Incensol Acetate
Component of Frankincense resin.
≥98% - U482046(-)-Umbellulone
Antimicrobial found in essential oils from plants.
≥98% - A5044Amlodipine Besylate
Dihydropyridine, FIASMA; L-type Ca2+ channel blocker.
≥98% - A5045Amlodipine
Dihydropyridine, FIASMA; L-type Ca2+ channel blocker.
≥98% - N3478Nitrendipine
Calcium channel blocker.
≥98% - I7468Isradipine
Calcium channel blocker.
≥98% - N3474Nisoldipine
Calcium channel blocker.
≥98% - C3446Cilnidipine
Dihydropyridine; L-type and N-type Ca2+ channel blocker.
≥98% - R3347Riluzole
Benzothiazole; TRPC5 agonist, PTR1 inhibitor, voltage-gated Na+ channel block...
≥98% - D3447Diltiazem Hydrochloride
Benzothiazepine; L-type Ca2+ channel blocker, potential CNG channel blocker.<...
≥98% - V1769Verapamil Hydrochloride
L-type Ca2+ channel blocker.
≥98% - New Product Spotlight: InhibitorsA 83-01 (LKT Product: A001001) A 83-01 is an inhibitor of ALK-5 (activin recepto...
- F4483Flufenamic Acid
NSAID; TREK1 K+ potentiator, voltage-gated Na+ channel blocker, TRPC3 and TRP...
≥97% - L1869Lercanidipine Hydrochloride
Calcium channel blocker.
≥98% - N3208Nicardipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥99% - Product Spotlight: Theaflavin, Theaflavin-3-gallate and Theaflavin-3, 3’-digallate from Black Tea ExtractsTheaflavin is a polyphenol found in black tea, along with related compounds thea...
- M0248Manidipine Dihydrochloride
Dihydropyridine; L-type and T-type Ca2+ channel blocker.
≥99% - N3228Nifedipine
Dihydropyridine; L-type Ca2+ channel blocker.
≥98% - N3448Nimodipine
L-type Ca2+ channel blocker.
≥98%